Summary: Date Posted: 12/30/2010 Size: 6.12MB Length: 00:13:48 Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar Health In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China. Play Podcast Download transcript and white paper For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
